Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.
Hyeong Kyu ParkKyoung-Ah KimKyung-Wan MinTae-Seo SohnIn Kyung JeongChul Woo AhnNan Hee KimIe Byung ParkHo Chan ChoChoon Hee ChungSung Hee ChoiKang Seo ParkSeoung-Oh YangKwan-Woo LeePublished in: Diabetes, obesity & metabolism (2023)
Dapagliflozin reduced total BF mass, abdominal VAT and SAT areas, and showed better glycaemic control than glimepiride. Being safe and well-tolerated, dapagliflozin appears to be a more favourable alternative to sulphonylureas as add-on therapy after metformin monotherapy failure in Korean patients with type 2 diabetes.